Tadokoro Tomoko, Tani Joji, Morishita Asahiro, Fujita Koji, Masaki Tsutomu, Kobara Hideki
Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki, Kita, Takamatsu 761-0793, Kagawa, Japan.
Cancers (Basel). 2024 Jul 14;16(14):2534. doi: 10.3390/cancers16142534.
Vascular invasion of hepatocellular carcinoma involves tumor plugs in the main trunk of the portal vein, bile ducts, and veins, and it indicates poor prognosis. It is often associated with portal hypertension, which requires evaluation and management. Treatment includes hepatic resection, systemic pharmacotherapy, hepatic arterial infusion chemotherapy, and radiation therapy. Recurrence rates post-hepatic resection are high, and systemic drug therapy often has limited therapeutic potential in patients with a poor hepatic reserve. Single therapies are generally inadequate, necessitating combining multiple therapies with adjuvant and systemic pharmacotherapy before and after hepatectomy. This narrative review will provide an overview of the treatment of hepatocellular carcinoma with vascular invasion.
肝细胞癌的血管侵犯包括门静脉主干、胆管和静脉中的肿瘤栓子,提示预后不良。它常与门静脉高压相关,需要进行评估和处理。治疗方法包括肝切除术、全身药物治疗、肝动脉灌注化疗和放射治疗。肝切除术后复发率很高,对于肝储备功能差的患者,全身药物治疗的治疗潜力往往有限。单一疗法通常并不充分,需要在肝切除术前和术后将多种疗法与辅助和全身药物治疗相结合。本叙述性综述将概述血管侵犯性肝细胞癌的治疗。